Shannon Thyme Klinger - 07 Jun 2021 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Legal Officer
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Issuer symbol
MRNA
Transactions as of
07 Jun 2021
Transactions value $
$0
Form type
4
Filing time
09 Jun 2021, 16:10:55
Previous filing
09 Jun 2021
Next filing
22 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Award $0 +42.2K $0.00 42.2K 07 Jun 2021 Common Stock 42.2K $219.57 Direct F1
transaction MRNA Restricted Stock Units Award $0 +18.2K $0.00 18.2K 07 Jun 2021 Common Stock 18.2K $0.00 Direct F2
transaction MRNA Restricted Stock Units Award $0 +9.11K $0.00 9.11K 07 Jun 2021 Common Stock 9.11K $0.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option will vest and become exercisable on June 7, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F2 25% of the shares subject to this restricted stock unit award will vest on June 7, 2022 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
F3 The shares subject to this restricted stock unit award will vest in full on June 7, 2024, subject to the recipient's continued service.